Turkish Journal of Medical Sciences
Volume 48

Number 6

Article 34

1-1-2018

Expression changes of CD177 and MPO as novel biomarkers in
lung tissue ofCLP model rats
AZADEH RASOOLI
ELHAM GHAFARI
HAMED SAEIDI
SABA MIRI

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
RASOOLI, AZADEH; GHAFARI, ELHAM; SAEIDI, HAMED; and MIRI, SABA (2018) "Expression changes of
CD177 and MPO as novel biomarkers in lung tissue ofCLP model rats," Turkish Journal of Medical
Sciences: Vol. 48: No. 6, Article 34. https://doi.org/10.3906/sag-1806-223
Available at: https://journals.tubitak.gov.tr/medical/vol48/iss6/34

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Turkish Journal of Medical Sciences

Turk J Med Sci
(2018) 48: 1321-1327
© TÜBİTAK
doi:10.3906/sag-1806-223

http://journals.tubitak.gov.tr/medical/

Research Article

Expression changes of CD177 and MPO as novel biomarkers in lung tissue of
CLP model rats
1,

1

2

3

Azadeh RASOOLI *, Elham GHAFARI , Hamed SAEDI , Saba MIRI 
Department of Biochemistry, Faculty of Sciences, Payame-e-Noor University, Tehran, Iran
2
Department of Biology, Damghan Branch, Islamic Azad University, Damghan, Iran
3
National Institute of Scientific Research (INRS-ETE), University of Quebec, Quebec City, Canada
1

Received: 28.06.2018

Accepted/Published Online: 11.11.2018

Final Version: 12.12.2018

Background/aim: Sepsis is an unregulated systemic response to microbial invasion that can lead to multiple organ failure. This study
aims at investigating the relationships among myeloperoxidase (MPO) and CD177 in major organ systems including whole blood, liver,
and lung tissues in septic rats.
Materials and methods: Sepsis was induced by cecal ligation and puncture (CLP) in female Wistar rats. Whole blood, liver, and lung
samples were obtained from rats of 3 groups (n = 10 for each group, n total = 30: control as a wild-type group, laparotomy group (LAP),
and CLP). Gene expression of MPO and CD177 in targeted tissues was determined by real-time PCR after CLP. MPO activity was also
determined by ELISA method for the result validation of the real-time PCR.
Results: Expression levels of MPO increased significantly in all targeted organs in the CLP group, while CD177 expression was
upregulated only in lung tissue in response to sepsis (P < 0.05). The results obtained with ELISA analysis also show that MPO level was
significantly increased in all the targeted tissues in the CLP group (P < 0.05).
Conclusion: A high level of MPO as an inflammatory enzyme can be a potentially novel biomarker for sepsis in all organs. On the other
hand, CD177 may be a marker in lung tissue.
Key words: Sepsis, gene expression, myeloperoxidase, CD177

1. Introduction
Sepsis is a life-threatening and complex inflammatory
response to infection with a variety of comorbidities.
After sepsis, the immune response is associated with a
major inflammatory response leading to shock, organ
dysfunction, and the development of immune alterations
that can directly or indirectly impair the function of almost
all types of immune cells (1,2). Some key inflammatory
enzymes, including myeloperoxidase (MPO), are involved
in the disease in question (3). The measurement of CD177
mRNA levels has also become a useful diagnostic tool for
distinguishing some diseases (4).
Neutrophils have various functions in the immune
system in some diseases such as sepsis, circulating
lipopolysaccharide (LPS) released from bacteria that
may activate both neutrophils and monocytes in whole
blood. The activated neutrophils release reactive oxygen
intermediates such as MPO with strong oxidative activity
(5). CD177 is an important neutrophil gene that encodes
the glycoprotein of the membrane and the expression of

this gene is increased during bacterial infections, burns,
and pregnancy (6–8).
Neutrophils are sequestered from the blood during
systemic inflammation, a process that is accompanied
by organ and tissue infiltration, including the liver and
lungs (9,10). The mechanisms mediating neutrophil
infiltration appear to be tissue-specific (11). Because of
the lack of knowledge on the relationship between CD177
and MPO as a biomarker for sepsis, we performed a gene
expression study on these genes in the response of systemic
inflammation in 3 main involved organs including whole
blood, the liver, and the lungs.
2. Materials and methods
2.1. Animal treatment
Female Wistar rats weighing between 120 and 150 g
were maintained at room temperature (22–23 °C) and
50% humidity in a controlled environment. Water and
food were available ad libitum. Animal experimentation
was performed according to ethical committee and
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institutional animal care and ethical guidelines. The
animals were divided into 3 groups (control, laparotomy
(LAP), and cecal ligation and puncture (CLP)). There were
ten rats in each group (n total = 30). Control groups did
not receive any surgical intervention. For LAP groups
the cecum was minimally handled without ligation and
puncture due to a combination of the effect of anesthesia,
laparotomy, mobilization of abdominal contents, and
postoperative analgesia (12).
2.2. Cecal ligation and puncture (CLP) model
The CLP model is described in Figure 1. First, the rats were
anesthetized by injections (i.p.) of a mixture of ketamine
(90 mg/kg b.w.) and xylazine (10 mg/kg b.w.). A small
midabdominal incision (2–3 cm) was made, as shown in
Figures 1a and 1b, and the cecum was exposed. A distended
portion of the cecum just distal to the ileocecal valve was
isolated (as shown in Figure 1c), filled with fecal content,
and tied with a 3-0 silk suture in a manner so as to not
disrupt bowel continuity (Figure 1d). The ligated portion
of the cecum was punctured twice with a 20-gauge needle
(Figure 1e). The cecum was then replaced in its original
position within the abdomen and the abdomen was then
closed with a 3-0 suture in two layers (Figure 1f). Then the
animals were allowed to recover. Immediately after surgery,

normal saline (3 mL/100 g b.w.) was subcutaneously given
to all rats as fluid resuscitation.
2.3. Sample collection
Blood samples were obtained from the hearts of the
rats. Heparinized blood was used for RNA extraction.
Immediately after death, the lungs and liver were excised
and washed with normal saline to remove blood, and then
were used for RNA extraction.
2.4. RNA extraction and reverse transcription
Total RNA was isolated from fresh peripheral whole blood
and lung and liver tissue. Total RNA was prepared with
an RNA Total Kit (BioBasic BS584, Canada). To ensure
that the sample of extracted RNA was not contaminated
with DNA, DNase treatment was carried out using DNase
I (SinaClon Co., Iran). cDNA was then synthesized using
the PrimeScript RT reagent kit (TaKaRa, Japan). Total RNA
was quantified by a NanoDrop 2000 spectrophotometer
(Thermo Scientific, USA). The same amount of RNA (ng)
in each reaction for cDNA synthesis was used. Primers
for real-time PCR were designed with the Gene Runner
software version 3.05 and BLASTn searches were used to
check primer specificity. Primers used in this study are
listed in the Table. The specific fragments were amplified
and then checked by 2% agarose gel electrophoresis

a

b

c

d

e

f

Figure 1. CLP procedure. A small midline incision (2–3 cm) is made through the skin (a, b). The cecum is identified and exposed (c).
The cecum is tightly ligated with a 3.0 silk suture at its base, below the ileocecal valve (d). The cecum is punctured twice with a 20-gauge
needle (e). The cecum is returned to the peritoneal cavity and the abdomen is stitched up with 3.0 silk sutures in two layers (f).
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Table. Primer sequences used in this study.
Primer

Sequence (5′ → 3′ )

Tmb (°C)

Forward CD177

ATACCAGTGCTG ACCCTTCTG

59.44

Reverse CD177

CCTCGCAGGTTT TCTCACC

60.25

Forward MPO

GCGATAGGTTTTGGTGGGAG

58.62

Reverse MPO

AGCTCACAAAGTCTCGGGG

57.89

Forward GAPDH

TGCCAGCCTCGTCTCATAG

58.88

Reverse GAPDH

ACTGTGCCGTTGAACTTGC

59.27

to ensure the specificity of primers and the size of PCR
products.
2.5. Real-time PCR
The expression of the selected gene was carried out
with a real-time PCR system (Rotor-Gene Q, QIAGEN,
Germany). The reaction mixture contained 5 µL of SYBR
Green Real-time PCR Master Mix (Rotor-Gene Q), which
contains Taq DNA polymerase, dNTP, MgCl2, SYBR Green
I dye, 0.2 µL of a 10 mM solution of sense/antisense primer,
100 ng of template cDNA, and H2O added to a total of 10
µL. Negative controls were also designed. Thermal cycling
conditions were carried out with an initial denaturation
stage at 95 °C for 2 min, followed by 40 cycles at 95°C
for 15 s, (61.2 °C for CD177, 59 °C for MPO, 60 °C for
GAPDH) for 20 s, and 72 °C for 20 s. At the completion of
each run, melting curves for the amplicons were measured
by raising the temperature by 0.3 °C from 57 to 95 °C while
monitoring fluorescence. To determine the specificity of
the PCR amplification, the melting curve for Tm, its
symmetry, and the lack of nonspecific peaks were checked.
All tests were conducted in triplicate. The expression
ratio was recorded as the fold difference in the quantity
of real-time PCR product from samples. Each mRNA
expression value was normalized against the threshold
cycle (CT) of a housekeeping gene expression (GAPDH),
and the fold change in the MPO and CD177 genes were
calculated by the formula 2–ΔΔCt as follows: ΔΔCt = (ΔCt
of the experimental test) – (ΔCt of control test). ΔCt was
calculated by subtracting the Ct of the target gene (MPO
or CD177) from the Ct of the reference gene (GAPDH).
2.6. Measurement of MPO by enzyme-linked
immunosorbent assay (ELISA)
For qPCR validation, MPO levels were measured by
the o-dianisidine-H2O2 method for 96-well plates (13).
From every sample, 20 µL was added to 0.53 mmol/L
o-dianisidine dihydrochloride (Sigma-Aldrich, USA),
and then 0.15 mmol/L H2O2 in 50 mmol/L potassium
phosphate buffer with pH 6.0. After 10 min of incubation
at room temperature, the change in absorbance was
measured at 460 nm. ELISA was performed with three
replicates for each sample.

Product (bp)
145
165
197

2.7. Statistical analysis
Data are presented as means ± standard error (SE). The
results were subjected to one-way ANOVA followed by
Tukey’s honestly significant differences test using SPSS
22.0 (IBM Corp., USA). The significance was considered
as P < 0.05.
3. Results
3.1. CD177 expression in whole blood, livers, and lungs
by real-time PCR
The results of CD177 expression showed a significant
difference in whole blood, livers, and lungs of the control
and two other groups (LAP and CLP). One-way ANOVA
revealed a significant effect of surgery by laparotomy
compared to the control group (P < 0.05). Furthermore, in
contrast with the CLP group (P > 0.05) in the liver, there
was no significant difference in the laparotomy group.
There were differences between LAP and CLP in whole
blood and lung tissue. CD177 gene expression increased
in response to surgery stress in the LAP group in all
tissues (Figure 2). As a result, when the level of infection
increased, we observed that the CD177 gene was expressed
more only in lung tissue.
3.2. MPO expression in blood, livers, and lungs by realtime PCR
Results showed that there was a significant difference
between the control group and two other groups in blood,
livers, and lungs. The CLP group significantly differed
from the control and LAP groups (P < 0.05). Compared
to control and LAP rats, the MPO of CLP rats showed a
significant increase. There was a relationship between
expression of the MPO gene and level of infection. We
observed that MPO gene expression increased in response
to infection in the CLP group in whole blood, the liver, and
lungs (Figure 3).
3.3. Analysis by ELISA of MPO level after CLP
One-way ANOVA analysis identified differences between
the increase of MPO activity and severity of sepsis in the
control group and two other groups (LAP and CLP) in
blood, livers, and lungs. The same significant increase was
observed between LAP and CLP (Figure 4). The results of
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Figure 2. The gene expression of CD177. *P < 0.05 is considered significant between the
control group and LAP group. **P < 0.05 is considered significant between the LAP group
and CLP group. Data are presented as mean ± SD.
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Figure 3. The gene expression of MPO. *P < 0.05 is considered significant between the control group and LAP group. **P < 0.05 is
considered significant between the LAP group and CLP group. Data are presented as mean ± SD.
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ELISA also confirmed the data obtained by real-time PCR
as MPO mRNA expression was upregulated in response
to infection in the CLP group in whole blood, livers, and
lungs (Figure 4).
4. Discussion
Sepsis and its sequelae remain the most common cause
of morbidity and mortality among critically ill patients in
intensive care units (14). Sepsis is initiated by immune cells
such as neutrophils, monocytes, and macrophages (15).
Neutrophils have a key role in controlling an immune
response to infection (16). During sepsis, reactive oxygen
species (ROS) are produced by activated neutrophils and
macrophages, which induce an inflammatory response
that causes structural membrane damage (17). MPO is also
one of the formations of ROS and oxidation of biological
substances and is involved in this structure (18,19).
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However, there is evidence that uncontrolled or excessive
accumulating of neutrophils lead to the development of
autoimmunity, the exacerbation of inflammation, and
tissue damage (20).
In severe sepsis, MPO is released in a high percentage
by activated neutrophils for antibacterial activities and
causes the increase of degranulated neutrophils (21). Like
others, we also observed that there was a relationship
between expression of MPO and level of infection (Figures
3 and 4).
Previous studies described that MPO composition
in myeloid-lineage cells usually increased as an
antiinflammatory activity in response to infection. During
the systemic inflammatory response, the aggregation of
neutrophils may be associated with enhanced neutrophilic
MPO activity (21). These observations confirm our result,
which shows that the mRNA level of MPO significantly
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Figure 4. Validation of gene expression results of MPO by ELISA. *P < 0.05 is considered significant between the control group and LAP
group. **P < 0.05 is considered significant between the LAP group and CLP group. Data are presented as mean ± SD.
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increased in the CLP group in whole blood, livers, and
lungs in response to infection (Figures 3 and 4).
In another context, Kothari et al. found that during
oxidative stress neutrophil activation occurs and the
number of cells increases during sepsis, and MPO
is released into the blood. The results of that study
showed that MPO activity may be a good biomarker for
inflammatory responses in septic patients (5).
In addition, CD177 is known as a neutrophil-specific
molecule that is involved in severe antibody-dependent
infections such as neonatal alloimmune neutropenia and
respiratory infection (22). Although CD177 increase was
formerly seen in the flow of neutrophils in response to LPS
of bacteria (23), we did not find any relationship between
expression of CD177 and level of infection in the liver
(Figure 2). One study confirmed a role of CD177 in the
neutrophil response to LPS of bacteria during neutrophil
transendothelial migration and an adhesion in which
neutrophil CD177 mRNA levels were increased, associated
with increased neutrophil counts (8). We found increased
CD177 mRNA expression in response to surgery in the
LAP group in whole blood, livers, and lungs, while CD177
expression was elevated in response to infection in the CLP
group in the lungs (Figure 2). These results suggest that
CD177 may have a role in the aggregation of neutrophils
in the lung tissue. If this process is not controlled, it can

lead to organ damage and severe infection. Thus, in cases
of respiratory infection that is worsened by uncontrolled
neutrophilic infection, CD177 may have a potential
contribution to treat respiratory inflammation (23). In
airspace neutrophils, the high level of CD177 expression
was identified as increased CD177-specific antibodies
of blood in acute lung injury, suggesting a potential
involvement of CD177 in neutrophil infiltration in
infectious diseases (22,24). Xie et al. also reported that the
number of neutrophils in a blood and skin infection model
was decreased in CD177 knockout animals (23). Another
interesting observation is that the MPO level was higher in
CD177- neutrophils (25).
The results in this study validate MPO increasing in
the CLP group in response to inflammation in all tissues,
but the expression of CD177 was elevated in response to
infection in the CLP group only in the lungs (Figures 2–4).
The finding of a positive correlation between the increased
expression of MPO and CD177 suggests that MPO and
CD177 may have potential as novel sepsis biomarkers
in the lungs, although further studies and assays such as
flow cytometry and immunohistochemical staining are
required to more clearly establish our results. Finally, this
study underscores the powerful potential of using the realtime PCR method to determine involvement of genes in
infectious diseases such as sepsis.
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